Update on the diagnosis and management of Behçet’s disease

por Rokutanda, Ryo, Kishimoto, Mitsumasa, Okada, Masato
Publicado no Open Access Rheumatol (2014)

Lupus Enteritis and Cystitis

por Kaneshita, Shunya, Kishimoto, Mitsumasa, Okada, Masato
Publicado no Intern Med (2017)

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)

por Yamaguchi, Ken-ichi, Kishimoto, Mitsumasa, Okada, Masato
Publicado em 2012

Mizoribine is as Effective as Methotrexate for the Treatment of Polymyalgia Rheumatica: A Retrospective Case Series Analysis

por SHIRAISHI, Kazushige, SUDA, Masei, ROKUTANDA, Ryo, KISHIMOTO, Mitsumasa, OKADA, Masato
Publicado no Arch Rheumatol (2018)

Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan

por Kishimoto, Mitsumasa, Yamairi, Fumiko, Sato, Noriko, Kobayashi, Jun, Yamauchi, Saori, Iwasaki, Tomohisa
Publicado no Rheumatol Ther (2021)

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 tria...

por Wei, James Cheng-Chung, Kim, Tae-Hwan, Kishimoto, Mitsumasa, Ogusu, Naoki, Jeong, Haeyoun, Kobayashi, Shigeto
Publicado no Ann Rheum Dis (2021)

The hospital educational environment and performance of residents in the General Medicine In-Training Examination: a multicenter study in Japan

por Shimizu, Taro, Tsugawa, Yusuke, Tanoue, Yusuke, Konishi, Ryota, Nishizaki, Yuji, Kishimoto, Mitsumasa, Shiojiri, Toshiaki, Tokuda, Yasuharu
Publicado em 2013

The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome: Controversies Revealed in a Multidisciplinary International Survey of Physicians

por Furer, Victoria, Kishimoto, Mitsumasa, Tsuji, Shigeyoshi, Taniguchi, Yoshinori, Ishihara, Yoko, Tomita, Tetsuya, Helliwell, Philip S., Elkayam, Ori
Publicado no Rheumatol Ther (2020)

Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japane...

por Yoshida, Kazuki, Kishimoto, Mitsumasa, Radner, Helga, Matsui, Kazuo, Okada, Masato, Saeki, Yukihiko, Solomon, Daniel H., Tohma, Shigeto
Publicado no Rheumatology (Oxford) (2016)

Reactive arthritis after COVID-19 infection

por Ono, Keisuke, Kishimoto, Mitsumasa, Shimasaki, Teppei, Uchida, Hiroko, Kurai, Daisuke, Deshpande, Gautam A, Komagata, Yoshinori, Kaname, Shinya
Publicado no RMD Open (2020)

An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety

por Yoshida, Kazuki, Tokuda, Yasuharu, Oshikawa, Hideto, Utsunomiya, Masako, Kobayashi, Tatsuo, Kimura, Makiko, Deshpande, Gautam A., Matsui, Kazuo, Kishimoto, Mitsumasa
Publicado em 2011

Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'

por Yoshida, Kazuki, Matsui, Kazuo, Nakano, Hiroto, Oshikawa, Hideto, Utsunomiya, Masako, Kobayashi, Tatsuo, Kimura, Makiko, Deshpande, Gautam A, Kishimoto, Mitsumasa
Publicado em 2011

Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psori...

por Coates, Laura C, Kishimoto, Mitsumasa, Gottlieb, Alice, Shuler, Catherine L, Lin, Chen-Yen, Lee, Chin Hyok, Mease, Philip J
Publicado no RMD Open (2017)

Clinical significance of monitoring hypothyroidism in patients with autoimmune rheumatic disease: a retrospective cohort study

por Fukui, Sho, Ikeda, Yukihiko, Kataoka, Yuko, Yanaoka, Haruyuuki, Tamaki, Hiromichi, Tsuda, Tokutarou, Kishimoto, Mitsumasa, Noto, Hiroshi, Ohde, Sachiko, Okada, Masato
Publicado no Sci Rep (2021)

Biologic Discontinuations Studies: A Systematic Review of Methods

por Yoshida, Kazuki, Sung, Yoon-Kyoung, Kavanaugh, Arthur, Bae, Sang-Cheol, Weinblatt, Michael E., Kishimoto, Mitsumasa, Matsui, Kazuo, Tohma, Shigeto, Solomon, Daniel H.
Publicado no Ann Rheum Dis (2013)

TNF Antagonist Responsiveness in a United States Rheumatoid Arthritis Cohort

por Greenberg, Jeffrey D., Kishimoto, Mitsumasa, Strand, Vibeke, Cohen, Stanley B., Olenginski, Thomas P, Harrington, Thomas, Kafka, Shelly P., Reed, George, Kremer, Joel M.
Publicado em 2008

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)

por Gottlieb, Alice B, Strand, Vibeke, Kishimoto, Mitsumasa, Mease, Philip, Thaçi, Diamant, Birt, Julie, Lee, Chin H, Shuler, Catherine L, Lin, Chen-Yen, Gladman, Dafna D
Publicado no Rheumatology (Oxford) (2018)

Use of Data from Multiple Registries in Studying Biologic Discontinuation: Challenges and Opportunities

por Yoshida, Kazuki, Radner, Helga, Kavanaugh, Arthur, Sung, Yoon-Kyoung, Bae, Sang-Cheol, Kishimoto, Mitsumasa, Matsui, Kazuo, Okada, Masato, Tohma, Shigeto, Weinblatt, Michael E., Solomon, Daniel H.
Publicado no Clin Exp Rheumatol (2013)

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies

por Hisamatsu, Tadakazu, Ueno, Fumiaki, Matsumoto, Takayuki, Kobayashi, Kiyonori, Koganei, Kazutaka, Kunisaki, Reiko, Hirai, Fumihito, Nagahori, Masakazu, Matsushita, Mitsunobu, Kobayashi, Kenji, Kishimoto, Mitsumasa, Takeno, Mitsuhiro, Tanaka, Masanori, Inoue, Nagamu, Hibi, Toshifumi
Publicado em 2013

Elevating the role of carers in rheumatoid arthritis management in the Asia‐Pacific region

por Pile, Kevin, Norager, Rachel, Skillecorn, Matthias, Gibson, Kathryn A., Elderton, Sue, Favorito, Wendy, Li, Zhanguo, Mu, Rong, Nakahara, Hideko, Kishimoto, Mitsumasa, Hirata, Shintaro, Kaneko, Yuko, Lau, Chak‐Sing, Tam, Lai‐Shan, Chen, Yi‐Hsing, Chen, Pearly, Wahking, Bryan, Furtner, Daniel
Publicado no Int J Rheum Dis (2020)